Viral pneumonia (known virus, not influenza)

VIRALPNEUMOKNOWN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B012\|B052\|B206\|B250\|J12[0-2]\|J171 Hospital discharge: ICD-9 — 480[0-2] Cause of death: ICD-10 — B012\|B052\|B206\|B250\|J12[0-2]\|J171 Cause of death: ICD-9 — 480[0-2] 2 out of 7 registries used, show all original rules.	823
4. Check minimum number of events None	823
5. Include endpoints None	823
6. Filter based on genotype QC (FinnGen only)	823

Control definitions (FinnGen only)

Control exclude: ASTHMA_PNEUMONIA

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	VIRALPNEUMOKNOWN
CONTROL_EXCLUDE	ASTHMA_PNEUMONIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B012\|B052\|B206\|B250\|J12[0-2]\|J171
HD_ICD_9	480[0-2]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B012\|B052\|B206\|B250\|J12[0-2]\|J171
COD_ICD_9	480[0-2]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Viral pneumonia (known virus, not influenza) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7453	3529	3892
Only index persons	5766	2742	3024
Unadjusted period prevalence (%)
Whole population	0.10	0.10	0.11
Only index persons	0.11	0.10	0.12
Median age at first event (years)
Whole population	29.10	37.36	21.47
Only index persons	53.85	61.94	46.52

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	823	377	446
Unadjusted period prevalence (%)	0.17	0.13	0.20
Median age at first event (years)	66.78	63.74	69.35

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
663: Matched controls
6630

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

323.0

417

J18.9

ICD-10 Finland

Pneumonia, unspecified

10.7

161.1

407

858

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.2

66.8

428

1989

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

8.2

66.0

160

246

J12.2

ICD-10 Finland

Parainfluenza virus pneumonia

+∞

52.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.5

50.7

213

627

J01MA14

ATC

moxifloxacin; systemic

7.1

49.6

131

222

C03CA01

ATC

furosemide; systemic

3.6

48.1

297

1217

WW200

NOMESCO Finland

Immunization

14.7

47.3

H02AB06

ATC

prednisolone; systemic

3.2

44.4

381

1960

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

7.0

43.5

115

193

R50.9

ICD-10 Finland

Fever, unspecified

4.3

43.3

186

548

4801A

ICD-9 Finland

Viral pneumonia, Pneumonia due to respiratory syncytial virus

+∞

43.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

42.3

149

357

R03AC02

ATC

salbutamol; inhalant

3.0

40.0

410

2315

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.9

38.4

138

335

127

Kela drug reimbursment

Transplant complication

18.4

37.9

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

7.9

37.4

127

J17.1*B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

36.8

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

6.2

35.6

102

189

J45.9

ICD-10 Finland

Asthma, unspecified

3.9

33.9

162

513

I50.9

ICD-10 Finland

Heart failure, unspecified

3.9

33.7

158

491

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

3.5

32.8

177

617

UGC12

NOMESCO Finland

Flexible bronchoscopy

5.3

32.8

107

231

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.6

32.7

173

594

R06.0

ICD-10 Finland

Dyspnoea

3.1

32.6

227

955

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

5.3

31.2

101

216

TGC00

NOMESCO Finland

Bronchial lavation

11.3

30.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

30.7

382

2270

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.7

30.6

153

499

B20.6

ICD-10 Finland

HIV disease resulting in Pneumocystis jirovecii pneumonia

+∞

29.4

J01MA12

ATC

levofloxacin; systemic

3.2

29.2

179

679

R03AK06

ATC

salmeterol and fluticasone; inhalant

3.8

29.1

137

423

TK800

NOMESCO Finland

Hemodialysis

10.8

28.8

L04AA06

ATC

mycophenolic acid; systemic

16.4

28.6

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.3

28.1

165

604

XW000

NOMESCO Finland

Bone marrow biopsy

6.4

27.4

130

L03AA02

ATC

filgrastim; parenteral

9.2

27.3

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

6.2

27.2

135

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

8.1

27.0

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.5

26.8

327

1868

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

6.9

25.8

104

H02AB04

ATC

methylprednisolone; systemic

3.5

25.4

133

445

J12.0

ICD-10 Finland

Adenoviral pneumonia

+∞

25.2

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

19.5

24.6

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

9.2

24.5

TPH04

NOMESCO Finland

Cathetrisation of vein

2.7

24.4

198

890

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

70.1

24.0

I50.0

ICD-10 Finland

Congestive heart failure

4.5

23.8

220

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.9

23.4

163

664

M04AA01

ATC

allopurinol; systemic

3.2

23.0

133

476

R03BB04

ATC

tiotropium bromide; inhalant

4.0

22.9

275

J46

ICD-10 Finland

Status asthmaticus

13.2

22.9

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

7.9

22.9

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

33.6

22.6

4800A

ICD-9 Finland

Viral pneumonia, Pneumonia due to adenovirus

+∞

22.0

B25.0

ICD-10 Finland

Cytomegaloviral pneumonitis

+∞

22.0

ZX108

NOMESCO Finland

Inhalation

26.1

21.9

Z94.0

ICD-10 Finland

Kidney transplant status

16.0

21.7

WX892

NOMESCO Finland

Monitored bed care

4.0

21.7

261

Z49.1

ICD-10 Finland

Extracorporeal dialysis

12.9

21.6

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

5.1

21.5

149

B23.8

ICD-10 Finland

HIV disease resulting in other specified conditions

113.6

20.7

J05AB11

ATC

valaciclovir; oral

3.2

20.7

119

422

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.3

20.6

240

1290

C90.0

ICD-10 Finland

Multiple myeloma

14.9

20.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

20.5

151

631

A28

ICPC

Limited function/disability NOS

2.9

20.5

145

591

L04AD01

ATC

ciclosporin; systemic

9.9

20.4

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

5.2

20.3

136

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.8

20.3

154

654

B03XA02

ATC

darbepoetin alfa; parenteral

9.1

19.9

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

4.4

19.7

183

A11CC03

ATC

alfacalcidol; systemic

7.5

19.7

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

7.2

19.6

Z2446

NOMESCO Finland

Social worker

3.8

19.4

259

JN4AD

NOMESCO Finland

Body CT examination

3.8

19.4

254

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

3.4

19.3

100

328

J45.1

ICD-10 Finland

Nonallergic asthma

4.6

19.2

159

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

21.6

18.7

A41.9

ICD-10 Finland

Sepsis, unspecified

5.7

18.6

101

XF400

NOMESCO Finland

ECG with 12 standard connections

2.7

18.4

147

641

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

7.1

18.3

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

4.2

18.1

188

ZX120

NOMESCO Finland

Intravenous

3.3

18.1

336

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

14.2

17.9

WX882

NOMESCO Finland

High dependency care

5.9

17.6

J01CA04

ATC

amoxicillin; systemic

2.4

17.5

549

4442

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.3

17.4

305

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

21.6

17.4

WW500

NOMESCO Finland

Blood transfusion

4.9

17.3

128

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

6.7

17.1

Z3231

NOMESCO Finland

Registered nurse

2.2

17.1

217

1195

JN4BD

NOMESCO Finland

Extensive body CT

3.1

17.1

104

380

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

51.4

17.1

153

Kela drug reimbursment

Lenalidomid

26.4

17.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

16.9

116

460

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.8

16.7

208

R03BA05

ATC

fluticasone; inhalant

2.5

16.5

144

656

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

23.8

16.5

GD1AD

NOMESCO Finland

Thorax CT examination

5.0

16.5

116

J01DB01

ATC

cefalexin; oral

2.2

16.5

535

4315

D64.9

ICD-10 Finland

Anaemia, unspecified

3.0

16.3

104

391

A02BC02

ATC

pantoprazole; systemic

2.0

16.2

412

2990

ZX112

NOMESCO Finland

Subcutaneous

7.8

16.1

L04AX04

ATC

lenalidomide; oral

25.2

16.1

N02AA05

ATC

oxycodone; systemic

2.6

16.1

128

552

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.7

16.0

117

482

B03XA01

ATC

erythropoietin; parenteral

15.0

15.9

B01AA03

ATC

warfarin; systemic

2.3

15.8

168

847

R02

ICPC

Shortness of breath/dyspnoea

2.9

15.8

101

381

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

4.0

15.8

176

J01MA02

ATC

ciprofloxacin; systemic

2.0

15.6

269

1672

N17.9

ICD-10 Finland

Acute renal failure, unspecified

5.3

15.5

J96.1

ICD-10 Finland

Chronic respiratory failure

8.3

15.5

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.3

15.4

175

906

J96.0

ICD-10 Finland

Acute respiratory failure

13.5

15.3

SPAT1254

SPAT

Administration of medicine

2.5

15.3

132

597

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

20.6

15.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

15.1

281

TPX10

NOMESCO Finland

Implantation of vascular injection port

5.8

14.9

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

25.7

14.8

A06AD11

ATC

lactulose; oral

2.6

14.7

120

523

A12AA04

ATC

calcium carbonate; oral

8.3

14.7

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

14.7

204

1154

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.0

14.6

314

H02AB09

ATC

hydrocortisone; systemic

6.3

14.4

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

7.0

14.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.9

14.3

165

V03AE02

ATC

sevelamer; oral

43.5

14.2

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

14.8

14.1

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

14.1

161

832

V03AE01

ATC

polystyrene sulfonate; oral

10.4

14.1

SPAT1263

SPAT

Sampling

1.9

14.1

302

2015

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

7.0

13.9

AA1AD

NOMESCO Finland

CT of head and brain

2.1

13.9

178

968

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

8.2

13.7

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.1

13.7

141

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.7

13.6

392

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

26.4

13.4

J01FA06

ATC

roxithromycin; oral

1.9

13.4

255

1620

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.5

13.4

115

515

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

9.3

13.3

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

10.0

13.3

A46

ICD-10 Finland

Erysipelas

2.6

13.3

107

464

Z49.0

ICD-10 Finland

Preparatory care for dialysis

12.5

13.2

N18.0

ICD-10 Finland

End-stage renal disease

11.3

13.1

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

11.3

13.1

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.5

13.1

189

C07AB07

ATC

bisoprolol; oral

1.9

13.1

311

2135

WX725

NOMESCO Finland

Noninvasive ventilation

4.3

13.0

122

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

6.5

12.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

12.9

278

1842

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

5.6

12.9

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.1

12.8

173

959

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

14.4

12.8

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

5.0

12.8

R81

ICPC

Pneumonia

5.1

12.7

N02BE01

ATC

paracetamol; systemic, rectal

2.1

12.6

543

4554

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

32.7

12.6

R4110

NOMESCO Finland

Physiotherapy

2.0

12.6

190

1101

D70.82

ICD-10 Finland

Drug-induced neutropenia

11.3

12.6

137

Kela drug reimbursment

Uraemia requiring dialysis

11.3

12.6

R05

ICPC

Cough

2.1

12.6

157

841

A03

ICPC

Fever

2.3

12.6

129

632

S97

ICPC

Chronic ulcer skin

3.8

12.6

147

SPAT1255

SPAT

Intravenous administration of medicine

3.4

12.6

190

J17.1*B01.2

ICD-10 Finland

Varicella pneumonia

+∞

12.5

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.4

12.5

196

J17.3*B59

ICD-10 Finland

Pneumonia due to Pneumocystis carinii

24.8

12.5

H02AB02

ATC

dexamethasone; systemic

2.7

12.3

349

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.8

12.3

306

C08CA01

ATC

amlodipine; oral

1.9

12.3

237

1505

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

38.3

12.2

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

7.2

12.2

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

16.2

12.2

R03BA02

ATC

budesonide; inhalant

2.3

12.0

117

558

H02AB07

ATC

prednisone; oral

2.5

12.0

102

453

L04AA01

ATC

[U] ciclosporin; systemic

7.8

12.0

TPH07

NOMESCO Finland

Cathetrisation of artery

2.6

12.0

392

N18.8

ICD-10 Finland

Other chronic renal failure

4.8

11.9

J01FF01

ATC

clindamycin; systemic

2.0

11.9

186

1089

R06.2

ICD-10 Finland

Wheezing

4.1

11.7

115

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.6

11.7

393

A04AA01

ATC

ondansetron; systemic, rectal

3.3

11.6

185

J05AB01

ATC

aciclovir; systemic

2.1

11.5

140

737

R96

ICPC

Asthma

3.0

11.5

232

J17.1

ICD-10 Finland

Pneumonia in viral diseases classified elsewhere

+∞

11.5

J20

ICD-10 Finland

Acute bronchitis

2.8

11.4

289

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.9

11.4

275

J45

ICD-10 Finland

Asthma

2.9

11.4

251

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

15.4

11.4

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

3.6

11.3

145

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

25.5

11.2

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

11.4

11.1

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.4

11.1

169

B01AB05

ATC

enoxaparin; parenteral

1.9

11.1

206

1279

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

10.3

11.1

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

44.1

10.9

R03AK07

ATC

formoterol and budesonide; inhalant

2.2

10.9

122

617

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

15.8

10.9

Z3226

NOMESCO Finland

Physiotherapist

2.1

10.8

139

748

A07AA02

ATC

nystatin; oral

3.2

10.8

190

WX872

NOMESCO Finland

Intensive care

3.5

10.8

151

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

10.7

225

1455

B02.9

ICD-10 Finland

Zoster without complication

3.3

10.7

174

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

3.1

10.7

197

J01AA02

ATC

doxycycline; systemic

1.8

10.7

469

3809

B97.4

ICD-10 Finland

Respiratory syncytial virus as the cause of diseases classified to other chapters

61.0

10.6

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

61.0

10.6

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.1

10.6

101

B05DA

ATC

Isotonic solutions

14.5

10.5

EBA15

NOMESCO Finland

Extraction of large number of teeth

4.2

10.5

B59

ICD-10 Finland

Pneumocystosis

+∞

10.4

M10.9

ICD-10 Finland

Gout, unspecified

3.3

10.4

166

ZXD05

NOMESCO Finland

Urgent procedure

1.8

10.3

216

1390

N06AX11

ATC

mirtazapine; oral

1.8

10.2

198

1241

XG410

NOMESCO Finland

Flow-volume spirometry

3.9

10.2

110

R53

ICD-10 Finland

Malaise and fatigue

2.0

10.1

143

796

AA1AA

NOMESCO Finland

Head X-ray examination

8.6

10.1

N02AX02

ATC

tramadol; systemic, rectal

1.7

10.1

263

1814

N05BA04

ATC

oxazepam; oral

1.9

10.0

162

952

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

7.8

10.0

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

9.9

208

L28

ICPC

Limited function/disability (L)

2.1

9.9

119

622

NJ3DA

NOMESCO Finland

Long bones of extremities X-ray examination

9.7

9.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.3

9.8

157

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

9.7

188

1178

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

5.2

9.7

WX730

NOMESCO Finland

Conventional respirator

6.5

9.6

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

5.8

9.6

R03DA04

ATC

theophylline; systemic, rectal

3.5

9.6

127

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

3.7

9.5

117

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

9.3

236

1602

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.3

9.3

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

9.3

130

721

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

7.4

9.3

N03AX16

ATC

pregabalin; oral

1.9

9.3

157

936

SPAT1301

SPAT

No procedures

1.7

9.2

221

1476

N19

ICD-10 Finland

Unspecified kidney failure

4.0

9.2

ZY010

NOMESCO Finland

Hospital outpatient

3.4

9.1

132

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.5

9.1

314

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

10.2

9.1

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

10.2

9.1

YNB10

NOMESCO Finland

Collection of stem cells for transplant

37.2

9.0

A04

ICPC

Weakness/tiredness general

2.2

9.0

495

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.2

9.0

441

TK810

NOMESCO Finland

Hemofiltration

24.4

8.9

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

8.9

219

1474

N30.0

ICD-10 Finland

Acute cystitis

2.2

8.8

452

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.4

8.7

126

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.9

8.6

184

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

8.6

107

567

R03DC03

ATC

montelukast; oral

2.1

8.6

497

WW300

NOMESCO Finland

Transfer of autologic stem cells

16.5

8.6

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.7

8.6

Z51.5

ICD-10 Finland

Palliative care

2.9

8.6

195

WX002

NOMESCO Finland

Sedation and analgesia

1.9

8.5

130

745

L04AX01

ATC

azathioprine; systemic

3.4

8.5

123

1CX01

NOMESCO Finland

27.9

8.5

D70.89

ICD-10 Finland

Neutropenic splenomegaly

7.5

8.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

8.4

341

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

8.4

103

538

1XX32

NOMESCO Finland

91.1

8.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

8.4

189

1232

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

8.4

147

883

H26.3

ICD-10 Finland

Drug-induced cataract

13.0

8.4

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

13.0

8.4

207

Kela drug reimbursment

Chronic arrhythmias

2.0

8.4

105

558

393

Kela drug reimbursment

Pomalidomide

+∞

8.3

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.6

8.3

255

B99

ICD-10 Finland

Other and unspecified infectious diseases

5.3

8.2

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

5.8

8.2

Z2221

NOMESCO Finland

Medical doctor

1.7

8.2

181

1172

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

8.3

8.1

V03AE03

ATC

lanthanum carbonate; oral

33.8

8.1

H05BX01

ATC

cinacalcet; oral

17.4

8.1

Z49.2

ICD-10 Finland

Other dialysis

10.2

8.1

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

3.9

8.0

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

5.6

8.0

K08.3

ICD-10 Finland

Retained dental root

2.8

8.0

193

ZXA00

NOMESCO Finland

Right side

1.7

8.0

174

1121

L03AA13

ATC

pegfilgrastim; parenteral

3.9

7.9

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

7.9

157

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

7.9

213

1456

B05DB

ATC

Hypertonic solutions

13.2

7.9

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.1

7.8

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

7.8

314

C03DA01

ATC

spironolactone; oral

2.2

7.7

378

3XA02

NOMESCO Finland

45.5

7.7

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.7

7.7

203

N05CF01

ATC

zopiclone; oral

1.7

7.7

200

1354

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

8.2

7.6

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

7.6

242

1730

WX722

NOMESCO Finland

PEEP

3.1

7.6

129

WX110

NOMESCO Finland

Local anesthesy

1.6

7.6

423

3483

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

25.3

7.6

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

9.0

7.6

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

5.9

7.6

WZC30

NOMESCO Finland

Teaching

2.1

7.6

459

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

10.2

7.6

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.4

7.5

108

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

5.1

7.5

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.4

7.4

279

A41.8

ICD-10 Finland

Other specified sepsis

6.1

7.4

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

13.5

7.4

XG466

NOMESCO Finland

Sleep oxymetry

3.6

7.4

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

3.4

7.4

104

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.3

7.4

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

8.5

7.3

SPAT1257

SPAT

Teaching of medicine inhalation technique

4.0

7.3

L04AX06

ATC

pomalidomide; oral

+∞

7.3

1507

Kela drug reimbursment

Pomalidomide

+∞

7.3

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

6.3

7.3

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

7.3

244

321

Kela drug reimbursment

Paricalcitol and cinacalcet

15.9

7.2

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.3

7.2

111

C02AC05

ATC

moxonidine; oral

3.1

7.2

128

N03AX12

ATC

gabapentin; oral

2.0

7.2

100

548

WX726

NOMESCO Finland

High-flow oxygen therapy

30.3

7.2

Z94.2

ICD-10 Finland

Lung transplant status

30.3

7.2

T86.0

ICD-10 Finland

Bone-marrow transplant rejection

30.3

7.2

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

7.2

268

1990

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

5.1

7.2

212

Kela drug reimbursment

Gout

5.4

7.1

SPAT1262

SPAT

Handing over of treatment supplies

1.8

7.1

127

766

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

8.9

7.1

R55

ICD-10 Finland

Syncope and collapse

2.1

7.1

384

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.7

7.0

178

SPAT1216

SPAT

Assessment of functional ability

1.9

7.0

102

570

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

3.2

7.0

114

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

6.4

7.0

SPAT1234

SPAT

Support of social functional capacity

2.8

6.9

156

K59.09

ICD-10 Finland

Constipation, unspecified

2.7

6.8

185

6BA02

NOMESCO Finland

11.1

6.8

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

11.1

6.8

R60.0

ICD-10 Finland

Localized oedema

2.2

6.8

360

K65.0

ICD-10 Finland

Acute peritonitis

9.4

6.8

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

6.8

163

1074

329

Kela drug reimbursment

Lenalidomide

16.9

6.8

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

6.8

C01AA05

ATC

digoxin; systemic

2.3

6.7

279

B34.9

ICD-10 Finland

Viral infection, unspecified

3.5

6.7

WW402

NOMESCO Finland

Leucoferesis

22.8

6.7

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

6.7

263

1966

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

6.7

192

1327

A05AA02

ATC

ursodeoxycholic acid; oral

5.3

6.7

N05CD07

ATC

temazepam; oral

2.0

6.7

425

RS220

NOMESCO Finland

5.6

6.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

6.6

387

A40.3

ICD-10 Finland

Sepsis due to Streptococcus pneumoniae

8.8

6.6

R03BA01

ATC

beclometasone; inhalant

2.0

6.6

434

J02AC01

ATC

fluconazole; systemic

1.6

6.6

200

1402

J96.9

ICD-10 Finland

Respiratory failure, unspecified

10.2

6.6

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

10.2

6.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

6.5

224

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.9

6.5

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.1

6.5

B01AB10

ATC

tinzaparin; parenteral

2.5

6.5

205

AN1

Coronary angiography

2.0

6.5

437

B01AF02

ATC

apixaban; oral

2.1

6.5

356

NB6AA

NOMESCO Finland

Humerus X-ray examination

4.3

6.5

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.2

6.4

281

L04AX02

ATC

thalidomide; oral

70.5

6.4

ZXE00

NOMESCO Finland

One hour or less

1.6

6.4

246

1826

205

Kela drug reimbursment

Chronic hypertension

1.6

6.4

176

1201

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

5.0

6.4

N05AH04

ATC

quetiapine; oral

1.9

6.3

556

196

Kela drug reimbursment

Paricalcitol and cinacalcet

18.2

6.3

GD1RA

NOMESCO Finland

Dynamic X-ray examination of respiratory organs with convetional X-ray picture

18.2

6.3

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

6.3

185

SPAT1325

SPAT

Vaccination

1.6

6.3

225

1644

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.1

6.2

107

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

6.2

319

L01BB05

ATC

fludarabine; systemic

26.9

6.2

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

6.2

237

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

6.2

166

1122

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

6.4

6.2

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

5.8

6.2

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

6.1

J45.8

ICD-10 Finland

Mixed asthma

3.8

6.1

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

6.1

115

702

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

6.1

158

1063

C01DA14

ATC

isosorbide mononitrate; oral

1.8

6.1

105

625

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

6.0

142

928

J01DA01

ATC

[U] cefalexin; systemic

1.5

6.0

366

2996

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

6.0

501

L57.0

ICD-10 Finland

Actinic keratosis

2.1

6.0

319

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

548

1114

12.73

305.96

3.2

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

427

777

10.34

254.64

2.7

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

422

783

10.01

246.40

2.9

1.8

—

(3023368) Bacteria identified in Blood by Culture

571

1846

7.84

184.03

8.4

4.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

165

156

12.98

156.92

2.9

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

153

12.06

139.65

3.1

1.8

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

135

140

11.34

119.62

10.1

6.6

iu/ml

17514.3

373.5

0.51

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

124

133

10.80

106.95

1.7

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

133

10.80

106.95

1.7

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

114

119

10.96

100.07

3.1

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

313

927

4.83

99.41

14.6

6.8

mmol/l

1.1

0.03

301

865

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

11.59

91.25

2.6

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

114

10.53

90.89

2.3

1.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

104

10.81

87.75

4.8

5.5

u/ml

92.2

2629.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

15.28

86.31

2.3

1.5

—

(44790048)

12.20

84.52

2.6

1.8

—

(44790047)

12.20

84.52

2.6

1.8

—

(44790049)

12.20

84.52

2.6

1.8

—

(44806118)

12.20

84.52

2.6

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

138

225

7.17

83.73

3.9

2.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

196

461

5.27

80.87

2.3

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

10.66

80.40

2.0

1.4

—

(3023419) Bacteria identified in Sputum by Culture

12.76

77.55

3.0

2.3

—

(42870588) Differential panel, method unspecified - Blood

482

2245

3.77

76.61

12.4

6.5

—

(3003396) Base excess in Arterial blood by calculation

251

754

4.35

75.84

9.7

7.8

mmol/l

2.0

0.9

2.97

206

595

(3027801) Oxygen [Partial pressure] in Arterial blood

250

751

4.34

75.51

9.8

7.7

kpa

10.5

12.4

7.32

238

723

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

250

751

4.34

75.51

9.8

7.7

kpa

5.3

5.1

1.64

237

722

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

10.66

74.60

1.9

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

220

613

4.53

73.17

17.1

8.4

mmol/l

11.0

9.6

1.82

213

587

(3016502) Oxygen saturation in Arterial blood

233

684

4.36

72.27

9.4

8.1

94.4

96.0

3.46

222

665

(3013115) Eosinophils [#/volume] in Blood

605

3381

3.98

70.40

13.7

6.3

e9/l

0.2

1.44

554

2949

(3013826) Glucose [Moles/volume] in Serum or Plasma

658

3895

4.44

70.24

10.8

5.3

mmol/l

7.1

6.7

3.64

633

3642

(3006504) Eosinophils/100 leukocytes in Blood

571

3077

3.79

70.18

13.3

6.2

2.5

2.9

3.45

550

2884

(3006315) Basophils [#/volume] in Blood

591

3273

3.86

69.24

12.3

6.1

e9/l

0.0

0.08

530

2813

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

10.93

69.15

2.8

1.8

—

(3022096) Basophils/100 leukocytes in Blood

559

2996

3.70

68.74

13.3

6.3

0.5

0.7

3.11

536

2816

(3019069) Monocytes/100 leukocytes in Blood

570

3094

3.74

68.67

14.2

6.4

8.5

8.8

0.78

547

2919

(3002032) Base excess in Venous blood by calculation

233

709

4.19

68.49

7.9

5.8

mmol/l

2.3

1.5

1.85

179

559

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

16.22

68.00

1.4

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

234

719

4.15

67.81

7.8

5.8

kpa

6.0

5.7

2.15

226

702

(3001604) Monocytes [#/volume] in Blood

585

3256

3.75

67.14

12.4

6.1

e9/l

0.7

0.6

4.99

525

2789

(3019198) Lymphocytes [#/volume] in Blood

595

3348

3.81

67.12

12.4

6.1

e9/l

2.2

2.0

0.63

538

2938

(3002030) Lymphocytes/100 leukocytes in Blood

575

3174

3.69

66.66

13.6

6.3

25.5

28.4

5.17

554

2977

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

135

269

5.81

66.41

2.6

1.8

ug/l

2.8

2.6

0.05

116

237

(3018010) Neutrophils/100 leukocytes in Blood

566

3132

3.58

64.50

13.0

6.1

59.5

56.5

5.02

544

2953

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

9.42

64.30

2.3

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

238

770

3.94

63.74

7.6

4.3

u/l

255.7

260.6

0.12

225

732

(21494815) CD4 cells/100 lymphocytes in Specimen

11.88

62.19

3.5

2.7

16.4

39.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

286

1068

3.57

61.51

7.2

4.4

mmol/l

0.8

0.21

271

1004

(3002173) Hemoglobin [Mass/volume] in Arterial blood

206

621

4.09

60.70

10.1

8.4

g/l

121.0

120.8

0.05

197

604

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

589

3428

3.53

59.96

12.6

6.4

umol/l

12.4

12.9

0.31

578

3242

(3013650) Neutrophils [#/volume] in Blood by Automated count

625

3796

3.69

58.86

21.9

9.2

e9/l

4.7

4.1

6.02

583

3301

(3019060) Gas panel - Arterial blood

165

437

4.47

57.65

7.5

5.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

181

515

4.22

57.51

5.8

2.6

g/l

9.3

10.5

2.40

169

475

(3024561) Albumin [Mass/volume] in Serum or Plasma

516

2825

3.22

57.20

11.5

5.1

g/l

33.0

35.5

16.11

495

2634

(3011412) CD3 cells [#/volume] in Blood

10.59

56.69

2.9

2.6

e9/l

1.1

1.2

0.19

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

160

423

4.45

55.94

2.2

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

536

3035

3.20

55.32

17.0

6.9

mmol/l

1.2

6.69

510

2765

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

13.06

55.19

3.5

3.1

31.3

41.0

0.92

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

11.08

54.96

2.7

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

11.08

54.96

2.7

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

11.08

54.96

2.7

1.7

—

(3000991) Gas panel - Venous blood

199

627

3.87

54.60

10.6

8.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

9.48

53.83

3.1

1.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

558

3297

3.15

52.17

20.7

7.5

mmol/l

1.2

4.82

491

2809

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

8.73

51.95

3.1

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

122

278

4.98

51.09

3.7

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

115

254

5.10

49.92

2.8

1.7

—

(3042936) Bacteria identified in Isolate by Culture

248

957

3.28

49.14

2.7

2.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

224

814

3.41

48.95

4.9

3.0

2.0

1.7

2.04

211

742

(3037692) Legionella sp identified in Specimen by Organism specific culture

16.54

48.04

2.0

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

150

426

4.08

47.23

10.4

7.3

mmol/l

25.4

24.2

2.15

139

405

(3032080) INR in Blood by Coagulation assay

481

2722

2.85

46.76

14.9

9.9

inr

1.3

0.00

119

784

(3007853) Bacteria identified in Skin by Aerobe culture

214

788

3.32

45.44

2.2

1.7

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

122

306

4.51

45.21

2.0

g/l

1.5

0.19

112

270

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

173

560

3.65

44.96

9.8

6.1

kpa

5.3

5.1

1.30

158

523

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

10.02

44.61

4.1

2.1

e6/l

409.3

758.5

1.26

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

130

346

4.27

44.57

13.4

10.9

—

(3009343) pH of Capillary blood

171

554

3.63

44.35

9.8

6.2

7.4

0.78

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

170

556

3.59

43.39

5.5

3.5

ng/l

249.0

217.3

0.36

156

507

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

10.36

43.11

2.1

3.0

9.9

10.9

0.15

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

165

532

3.63

43.02

9.9

6.3

mmol/l

2.3

1.4

1.76

139

401

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

13.43

42.85

3.2

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

13.43

42.85

3.2

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

13.43

42.85

3.2

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

13.43

42.85

3.2

1.7

—

(3028026) IgM [Mass/volume] in Serum or Plasma

144

429

3.86

42.14

3.5

1.7

g/l

1.4

1.5

0.14

132

399

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

214

4.95

41.00

4.2

5.3

u/ml

0.3

0.4

0.37

115

(3031040) Bacteria [#/volume] in Urine by Automated count

644

4417

3.11

40.84

7.7

4.5

e6/l

20.8

2579.8

1.41

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

379

1997

2.66

40.82

4.8

3.1

ng/l

3580.8

1466.7

4.11

349

1715

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

150

5.72

40.39

2.0

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

140

423

3.78

40.04

6.2

6.7

mmol/l

24.3

23.8

0.82

132

386

(3014111) Lactate [Moles/volume] in Serum or Plasma

175

613

3.36

39.87

9.0

8.3

mmol/l

1.6

1.4

0.71

170

578

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

292

1364

2.77

39.81

2.2

2.1

mg/l

1.7

1.3

0.71

243

1047

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

139

5.84

39.33

2.1

1.5

u/ml

191.4

97.1

0.57

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

274

1254

2.78

38.69

6.8

3.8

ng/l

119.8

401.9

2.18

245

998

(3037756) Immunofixation for Serum or Plasma

145

5.67

38.63

2.4

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

177

5.17

38.25

1.5

1.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

221

913

2.94

37.73

5.2

2.6

20.8

22.7

1.22

184

791

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

379

2058

2.56

37.56

6.2

3.4

u/l

33.5

34.0

0.06

362

1966

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

10.73

37.15

13.4

6.2

u/ml

50.4

86.8

0.41

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

426

2455

2.52

37.01

6.0

3.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

228

970

2.87

36.76

5.1

2.5

g/l

2.2

2.3

3.23

217

899

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

9.28

36.61

2.3

3.0

—

(3047181) Lactate [Moles/volume] in Blood

196

4.85

36.60

11.9

8.1

mmol/l

1.3

1.4

0.23

173

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

683

4967

3.20

36.48

17.2

7.4

u/l

88.8

82.6

1.59

665

4637

(3022948) Iron [Moles/volume] in Serum or Plasma

241

1062

2.79

36.29

5.0

2.5

umol/l

10.8

12.9

5.33

226

981

(3020630) Protein [Mass/volume] in Serum or Plasma

158

550

3.32

36.13

5.8

3.0

g/l

64.3

66.2

1.96

144

498

(3017143) Hepatitis C virus Ab [Presence] in Serum

191

750

3.01

35.53

3.0

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

368

2017

2.49

35.16

3.6

2.5

u/l

48.0

56.3

7.48

350

1863

(3024354) Oxygen [Partial pressure] in Venous blood

170

629

3.15

35.04

6.8

5.5

kpa

4.9

4.7

0.46

164

611

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

9.57

35.03

2.8

1.5

—

(3026008) Bacteria identified in Urine by Culture

367

2013

2.49

34.96

4.6

3.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

242

1088

2.73

34.87

3.3

2.8

30.4

29.7

0.84

236

1055

(3014576) Chloride [Moles/volume] in Serum or Plasma

207

858

2.89

34.83

10.8

7.3

mmol/l

102.9

104.4

3.51

198

843

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

205

4.63

34.62

7.5

3.9

mg/l

35.2

34.7

0.04

169

(3019309) Folate [Moles/volume] in Red Blood Cells

265

1251

2.65

34.60

2.0

1.7

nmol/l

1206.5

1184.9

0.13

217

941

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

8.60

34.51

3.0

2.5

e6/l

644.1

456.7

1.24

(3037467) Urinalysis macro (dipstick) panel - Urine

641

4571

2.82

34.20

7.8

4.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

203

4.61

34.14

7.3

3.9

ratio

1.4

1.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

205

4.57

33.71

7.5

3.9

mg/l

120.6

85.4

0.28

166

(3018418) pH of Serum or Plasma

353

1929

2.45

33.57

10.4

3.8

7.4

0.78

376

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

113

331

3.80

33.57

9.5

10.1

mmol/l

24.7

24.4

0.39

105

307

(3004588) Protein electrophoresis panel - Serum or Plasma

135

445

3.43

33.55

5.7

2.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

18.58

33.52

2.1

2.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

153

5.14

33.37

1.9

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

211

4.49

33.36

1.8

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

162

602

3.11

33.01

4.8

3.0

e9/l

72.8

68.8

0.71

125

459

(40760888) Immunoglobulin light chains.free panel - Serum

151

5.13

32.88

7.7

4.2

—

(40758558) Short blood count panel - Blood

315

1657

2.46

32.33

14.5

6.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

8.35

32.24

3.0

2.5

e9/l

0.2

0.11

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

8.35

32.24

4.8

3.1

—

(3000494) Fungus identified in Specimen by Culture

186

759

2.87

31.97

2.4

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

6.19

31.72

4.8

3.7

1.4

1.6

0.10

(3015235) Bicarbonate [Moles/volume] in Capillary blood

186

4.59

31.41

6.9

3.5

mmol/l

26.1

24.8

1.86

162

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

7.27

31.24

1.4

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

109

328

3.68

31.05

9.4

3.8

mmol/l

25.6

24.8

0.93

101

321

(3021879) Hepatitis B virus core Ab [Presence] in Serum

136

472

3.25

30.99

2.3

1.5

—

(3002582) Erythrocytes [#/volume] in Urine

364

2082

2.34

30.49

5.7

3.5

e6/l

31.2

97.6

1.30

296

1607

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

410

2469

2.32

30.39

6.2

3.7

ng/l

74.5

41.0

0.98

326

1781

(3022313) Gas panel - Capillary blood

128

434

3.31

30.27

10.1

6.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

6.83

30.10

2.8

2.5

—

(3002179) Metamyelocytes/100 leukocytes in Blood

132

464

3.20

29.37

5.9

4.5

1.0

0.4

1.69

119

(3018095) Leukocytes [#/volume] in Urine

400

2409

2.28

29.33

6.5

4.0

e6/l

55.6

133.1

1.17

303

1716

(3017181) Myelocytes/100 leukocytes in Blood

140

512

3.09

29.11

6.4

4.6

1.1

0.9

0.44

161

(3000850) Epithelial cells [#/volume] in Urine

274

1416

2.40

28.62

4.5

2.6

e6/l

5.7

5.2

0.26

254

1250

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

137

501

3.08

28.45

7.9

4.5

ng/l

123.2

79.8

4.16

122

446

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

318

1762

2.31

28.19

3.4

2.2

mg/l

3.1

3.0

0.36

288

1493

(3018572) Chloride [Moles/volume] in Blood

151

4.74

28.06

12.4

8.9

mmol/l

103.6

105.4

1.92

140

(3039000) Anion gap in Blood

151

4.74

28.06

12.4

8.9

mmol/l

11.7

11.5

0.10

140

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

11.10

27.01

4.0

1.8

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

11.10

27.01

4.0

1.8

—

(36304419) Bacteria [Presence] in Urine

325

1848

2.25

26.78

5.5

3.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

113

5.24

26.66

2.6

1.9

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

17.36

26.42

2.3

2.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

10.70

26.36

4.2

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

6.76

26.22

1.6

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

467

3087

2.19

26.16

7.3

4.1

—

(3044640) Blood type and Crossmatch panel - Blood

354

2102

2.20

26.03

4.8

2.5

—

(3030467) Casts [#/volume] in Urine by Automated count

330

1910

2.21

25.82

5.6

3.3

e6/l

0.6

0.4

0.43

259

1440

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

337

1973

2.20

25.56

2.9

2.1

u/l

227.8

268.6

0.23

323

1848

(3001122) Ferritin [Mass/volume] in Serum or Plasma

438

2841

2.16

25.54

4.8

2.8

ug/l

326.4

132.5

0.90

416

2604

(3026493) Urate [Moles/volume] in Serum or Plasma

299

1672

2.24

25.39

6.4

3.0

umol/l

1420.4

7388.1

3.27

269

1437

(46235355) HIV 1 and 2 tests - Meaningful Use set

236

1195

2.37

25.36

2.4

1.9

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

8.20

25.29

2.4

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

9.16

25.20

2.1

2.7

u/ml

1714.6

568.2

—

(3026782) Osmolality of Urine

255

1343

2.30

24.94

4.8

2.9

mosm/kgh2o

523.2

555.9

1.70

233

1148

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

272

3.55

24.62

10.7

6.4

2.0

1.6

2.41

258

(3008536) Aspergillus sp Ab [Presence] in Serum

15.04

24.57

3.0

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

106

364

3.19

24.35

1.6

1.3

u/ml

395.2

256.2

0.38

331

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

289

1617

2.21

24.30

3.8

2.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

272

3.50

23.92

10.8

6.4

0.9

0.12

258

(3033658) Prothrombin time (PT) actual/Normal

295

1675

2.19

23.82

7.7

4.5

83.1

87.9

2.25

290

1643

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

159

4.28

23.68

1.7

1.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

775

6557

4.12

23.07

46.2

14.4

mg/l

32.8

24.5

9.03

741

5183

(3028433) Virus identified in Specimen by Culture

10.29

23.03

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

140

582

2.69

22.68

3.3

2.5

ug/l

5.6

7.3

0.83

128

518

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

151

4.28

22.67

1.7

1.5

u/ml

283.2

272.1

0.08

(3042631) Mycobacterium sp identified in Specimen

5.14

22.53

2.1

2.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

8.55

22.37

2.6

1.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

560

4109

2.14

22.29

4.0

3.0

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

146

625

2.62

22.28

2.7

2.4

u/l

27.6

39.5

0.96

132

525

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

8.31

21.87

2.6

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

625

4804

2.25

21.83

7.0

4.0

mm/h

19.7

12.2

16.01

595

4395

(3028626) Oxygen [Partial pressure] in Capillary blood

278

3.34

21.75

9.0

7.5

kpa

8.1

8.8

3.18

258

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

107

395

2.96

21.62

1.7

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

12.65

21.26

4.0

1.5

—

(4010399)

110

417

2.89

21.17

1.8

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

352

2223

2.02

20.74

6.8

3.3

mmol/l

2.3

2.4

7.64

307

1941

(3048929) Epstein Barr virus Ab [Presence] in Serum

246

3.40

20.49

1.7

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

226

3.50

20.44

3.3

5.5

91.3

89.5

0.26

217

(3021440) Promyelocytes/100 leukocytes in Blood

120

487

2.71

20.27

6.8

4.7

0.1

0.03

148

(1616796) Gas panel - Central venous blood

142

4.16

20.15

6.9

3.7

—

(3021901) Oxygen saturation in Capillary blood

129

4.32

20.12

5.8

2.6

—

(21494434) Karyotype in Bone marrow

5.82

20.07

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

5.74

19.76

5.4

3.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

8.36

19.72

1.7

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

188

3.67

19.47

2.8

1.7

—

(3042733) HLA Ab [Presence] in Serum

10.25

19.44

4.1

4.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

108

425

2.77

19.33

10.0

5.3

g/l

124.8

125.7

0.13

102

418

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

194

1002

2.22

19.26

2.4

1.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

3.30

19.14

5.7

2.6

g/l

7.1

7.3

0.39

186

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

3.30

19.14

5.7

2.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

3.30

19.14

5.7

2.6

g/l

4.0

3.8

0.22

179

(3021960) Folate [Moles/volume] in Serum or Plasma

270

1589

2.04

19.03

1.8

1.6

nmol/l

19.0

20.4

0.81

244

1353

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

188

3.61

18.73

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

218

1194

2.12

18.57

4.0

3.0

e6/l

1.0

0.9

0.15

130

698

(3036481) Cortisol [Moles/volume] in Serum or Plasma

135

605

2.47

18.53

2.7

2.0

nmol/l

352.2

372.9

0.54

121

559

(3036489) Thrombin time

257

3.20

18.44

3.1

3.9

21.5

21.8

0.19

240

(3035350) Ketones [Presence] in Urine by Test strip

455

3224

1.92

18.39

5.1

3.7

estimate

0.0

0.00

611

(3022217) INR in Platelet poor plasma by Coagulation assay

174

875

2.25

18.35

40.8

26.3

inr

1.6

1.3

1.61

122

(3009261) Glucose [Presence] in Urine by Test strip

460

3279

1.91

18.17

5.2

3.8

estimate

0.0

0.50

600

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

208

1133

2.12

17.90

4.4

3.3

e6/l

2.0

1.8

0.13

119

640

(3021601) Nitrite [Presence] in Urine by Test strip

454

3236

1.90

17.80

6.9

5.1

estimate

0.0

0.00

620

(3037121) Protein [Mass/volume] in Urine

276

3.06

17.51

6.4

3.9

g/l

0.2

0.3

1.60

127

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

230

3.23

17.19

5.4

2.6

g/l

9.8

10.4

0.41

195

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

232

3.20

16.95

6.0

2.6

g/l

3.1

3.2

0.21

183

(3023199) Leukocytes [#/volume] in Pleural fluid

4.81

16.72

1.4

1.3

e6/l

1265.5

2015.6

0.51

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

379

2594

1.85

16.44

3.2

2.3

nmol/l

76.7

76.4

0.05

347

2294

(3003434) Protein [Mass/volume] in Pleural fluid

4.52

16.30

1.5

g/l

29.6

30.6

0.19

(40757373) Influenza virus identified in Isolate

11.55

16.25

2.6

1.6

—

(3024932) HLA-DR beta [Type]

8.05

16.22

1.2

1.1

—

(3024471) HLA-A [Type]

8.05

16.22

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

9.70

16.16

2.5

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

4.40

16.13

1.3

1.6

g/l

0.8

0.07

(3003181) Sodium [Moles/volume] in Urine

110

4.17

16.13

3.1

1.5

mmol/l

72.6

60.8

0.94

(40760892) CBC W Ordered Manual Differential panel - Blood

236

1391

1.98

16.13

8.4

4.4

—

(3025159) Blasts/100 leukocytes in Blood

107

459

2.53

16.03

6.7

4.7

0.1

0.8

0.48

126

(3052592) Norovirus Ag [Presence] in Stool

13.87

15.95

1.7

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

6.52

15.91

2.0

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

6.52

15.91

2.0

1.5

—

(3021589) Normoblasts [#/volume] in Blood

419

2981

1.83

15.84

21.4

10.0

e9/l

0.0

0.25

344

2433

(3027456) Digoxin [Moles/volume] in Serum or Plasma

140

3.74

15.69

4.1

3.1

nmol/l

0.8

0.9

0.29

111

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

388

2702

1.82

15.69

2.5

2.0

pmol/l

92.1

94.0

0.33

226

1405

(3017704) Immunofixation for Urine

6.17

15.67

2.5

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

206

3.23

15.59

3.3

4.1

211.8

181.9

1.45

197

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

116

3.95

15.02

1.4

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

8.17

14.94

3.5

4.2

—

(3012501) Base excess in Blood by calculation

145

3.61

14.91

9.4

4.2

mmol/l

2.9

2.4

0.53

(3023183) Ammonium ion [Moles/volume] in Plasma

165

3.43

14.88

2.9

3.9

umol/l

30.7

36.2

1.22

147

(3037522) Nuclear Ab [Titer] in Serum

154

800

2.14

14.73

1.4

1.3

titre

696.0

450.6

0.49

166

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

105

4.06

14.56

1.1

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

111

3.93

14.30

1.2

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

4.38

14.21

6.4

3.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

5.07

14.14

5.4

3.3

57.2

56.1

0.07

(3020891) Body temperature

271

2.82

13.94

9.4

4.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

150

787

2.11

13.93

5.6

3.3

umol/l

10.9

8.7

0.43

128

689

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

24.27

13.83

2.9

1.4

—

(3045142) Bone marrow Pathology biopsy report

4.36

13.74

2.0

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

8.34

13.67

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

226

1377

1.88

13.66

2.3

1.5

g/l

2.4

0.02

153

821

(3028308) Erythrocytes [#/volume] in Pleural fluid

4.54

13.66

1.5

1.3

e6/l

23889.5

33389.0

0.30

(3006184) Hemoglobin [Mass/volume] in Capillary blood

139

3.53

13.62

3.4

2.2

g/l

128.8

129.5

0.07

108

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

771

6894

2.87

13.12

22.3

10.3

u/l

26.1

26.3

0.05

759

6628

(3011397) Hemoglobin [Presence] in Urine by Test strip

242

1525

1.83

13.06

4.8

3.8

—

(3010421) pH of Blood

180

3.14

12.95

9.3

3.9

7.4

0.09

143

(40768446) Kidney Pathology biopsy report

7.18

12.74

2.1

1.8

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

9.53

12.58

1.3

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

217

2.90

12.49

6.2

2.9

g/l

1.7

1.0

0.55

190

(40767503) Oxygen content in Capillary blood by calculation

142

3.37

12.49

4.3

2.2

16.1

0.01

(21494890) Protein electrophoresis panel - 24 hour Urine

4.54

12.46

3.2

2.4

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

127

655

2.11

12.25

3.0

2.6

g/l

0.2

0.14

116

614

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

150

3.26

12.11

2.1

1.4

—

(3012516) Albumin [Mass/volume] in Urine

280

1877

1.75

12.09

4.7

3.3

mg/l

1392.3

259.0

1.67

213

1232

(3045788) Cell count panel - Pleural fluid

4.64

11.96

1.6

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

4.70

11.72

1.4

1.2

g/l

2.7

3.0

0.17

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

203

2.89

11.62

1.7

1.4

g/l

0.2

0.11

193

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

8.47

11.52

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

114

3.54

11.51

6.4

3.5

56.8

58.0

0.15

114

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

520

4146

1.69

11.51

5.4

3.2

u/l

61.3

49.0

2.19

489

3867

(3009871) Measles virus Ab [Titer] in Serum

10.14

11.36

1.7

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

164

3.05

11.05

1.4

2.0

mg/l

24.2

12.4

0.62

149

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

8.02

11.04

1.3

1.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

4.52

10.79

1.4

1.2

g/l

0.4

0.22

(3027135) IgG subclass 1 [Mass/volume] in Serum

4.52

10.79

1.4

1.2

g/l

6.0

7.2

0.85

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.83

10.67

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

190

2.85

10.64

3.6

3.5

—

(4062490)

4.44

10.57

1.4

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.90

10.53

2.8

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.90

10.53

2.8

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

10.13

10.46

1.4

1.3

—

(3025941) Bacteria identified in Stool by Culture

365

2.32

10.39

1.6

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

3.74

10.33

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

210

1348

1.75

10.31

1.8

1.7

pmol/l

465.3

9674938.9

0.80

180

1106

(3009508) Creatinine [Moles/volume] in Urine

296

2085

1.66

10.28

5.0

3.2

mmol/l

6.7

7.7

3.33

252

1736

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

189

2.81

10.17

1.8

1.5

iu/ml

0.1

0.29

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

4.41

10.10

1.6

1.3

—

(3044889) 12 lead EKG panel

542

4447

1.64

9.99

5.9

3.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

110

3.38

9.95

5.2

3.2

e9/l

4.2

0.01

110

(3043409) Potassium [Moles/volume] in Arterial blood

206

2.68

9.67

4.6

3.6

mmol/l

4.0

3.9

0.14

193

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

578

4839

1.65

9.65

4.3

3.7

pmol/l

15.0

14.8

1.33

539

4349

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

10.12

9.56

1.2

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

170

2.81

9.24

1.2

1.1

—

(3000492) Spirometry study

104

552

2.01

9.21

2.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

5.39

9.19

2.3

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

5.39

9.19

2.3

1.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

161

2.83

9.00

1.3

—

(3012441) Differential panel - Pleural fluid

3.79

8.95

1.6

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

669

5882

1.73

8.61

5.3

4.5

mu/l

2.0

0.63

620

5323

(4035726)

103

558

1.97

8.60

1.7

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

277

1990

1.59

8.55

5.1

4.0

mg/mmol

19.1

19.2

0.01

201

1277

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

8.56

8.48

1.2

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

8.56

8.48

1.1

1.0

87.2

91.8

0.19

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.50

8.28

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

3.60

8.02

1.2

1.3

—

(40758292) HTLV I+II Ab panel - Serum

7.15

8.01

2.0

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

7.95

8.00

1.6

4.8

—

(3007461) Platelets [#/volume] in Blood

784

7302

2.55

8.00

59.8

21.2

e9/l

238.0

246.3

2.44

779

7100

(3026361) Erythrocytes [#/volume] in Blood

784

7306

2.54

7.91

59.6

21.2

e12/l

4.3

4.5

22.27

778

7083

(3019977) pH of Arterial blood

4.94

7.91

2.2

4.6

7.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

138

2.84

7.90

1.5

1.7

—

(3010813) Leukocytes [#/volume] in Blood

784

7308

2.54

7.87

59.7

21.2

e9/l

7.9

6.8

10.02

779

7082

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

3.37

7.85

2.5

1.5

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

5.44

7.75

2.9

3.1

ug/l

62.4

90.8

0.50

(3025468) Yersinia sp identified in Specimen by Organism specific culture

3.34

7.71

2.5

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

3.34

7.71

2.5

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

3.79

7.67

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

3.30

7.58

2.5

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

3.30

7.58

2.5

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

3.30

7.58

2.5

1.5

—

(40761511) CBC panel - Blood by Automated count

742

6794

1.94

7.47

38.0

13.5

—

(3019225) pH of Specimen

108

623

1.84

7.44

13.9

4.4

—

(3047189) Immunofixation for 24 hour Urine

4.92

7.43

3.0

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

4.92

7.43

4.2

3.6

—

(3002385) Erythrocyte distribution width [Ratio]

626

5479

1.60

7.42

48.6

17.7

14.4

13.6

21.80

620

5374

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

205

2.42

7.26

1.5

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

4.78

7.19

2.1

3.1

e6/l

6440.0

416.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

116

694

1.78

7.08

6.5

3.2

—

(3035880) pH of Pleural fluid

4.26

7.04

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.62

6.90

1.3

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

13.91

6.90

3.6

2.0

—

(3024928) Oxygen saturation in Venous blood

155

2.59

6.86

5.5

7.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

670

5997

1.63

6.85

43.5

15.6

37.9

39.7

5.76

451

4265

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

126

2.77

6.84

1.4

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

106

630

1.78

6.61

2.3

1.7

—

(1761868) Lipid panel - Serum or Plasma

144

2112

0.61

6.52

3.2

2.8

—

(3048879) Bone marrow aspiration report

6.18

6.44

2.6

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

3.79

6.39

1.1

1.4

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

6.74

6.32

4.1

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

3.57

6.19

1.1

1.0

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

482

1.85

6.18

3.2

2.9

ml/min/173m2

51.2

66.0

2.20

205

(3003694) ABO and Rh group [Type] in Blood

250

1863

1.49

6.16

1.5

—

(3019150) Specific gravity of Urine by Refractometry

204

1459

1.53

6.11

5.7

4.0

kg/l

1.0

0.88

225

(3047007) Chlamydophila sp Ab [Presence] in Serum

2.98

6.04

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

15.14

5.91

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

15.14

5.91

1.2

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

15.14

5.91

1.2

1.0

—

(3022621) pH of Urine by Test strip

452

1.85

5.89

3.3

2.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

5.56

5.82

1.2

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

4.43

5.78

1.3

1.9

u/field

2.0

2.8

—

(3017732) Neutrophils [#/volume] in Blood

425

1.87

5.78

4.3

2.7

e9/l

5.5

3.9

3.19

329

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

183

2.31

5.67

1.2

1.3

miu/ml

228.1

257.7

0.17

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

147

2.44

5.54

2.1

2.2

e6/l

101.8

113.7

0.05

117

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

147

2.44

5.54

2.0

2.2

e6/l

19.4

31.2

0.21

112

(3045462) Protein/Creatinine [Ratio] in Urine

5.30

5.53

5.8

6.4

g/mol

17.7

2803.8

0.49

(3044290) Cell count panel - Cerebral spinal fluid

129

2.54

5.51

2.0

2.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

194

2.23

5.37

1.9

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

138

2.45

5.28

4.2

3.9

mg/l

33.2

26.7

0.32

(3017817) Protein [Mass] in Urine collected for unspecified duration

3.27

5.19

2.2

2.6

—

(40768806) Pleura Pathology biopsy report

2.89

5.12

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

104

2.65

5.10

5.4

3.2

—

(3044927) Protein electrophoresis panel - Urine

2.95

5.06

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

233

1774

1.44

4.97

4.8

3.3

—

(3029937) Albumin [Presence] in Urine by Test strip

232

1767

1.44

4.94

6.2

4.0

estimate

0.0

0.88

596

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

312

2504

1.40

4.93

5.9

3.9

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

170

1225

1.49

4.81

4.2

3.0

mmol/l

2.5

2.4

0.30

139

1074

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

102

2.60

4.75

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

103

2.57

4.67

1.2

1.1

—

(3017569) Oxygen content in Arterial blood

3.73

4.66

2.2

3.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

8.26

4.57

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

3.87

4.55

1.0

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

4.81

4.54

4.5

38.9

48.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

10.08

4.52

1.3

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

10.08

4.52

4.3

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

7.57

4.36

9.2

9.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

101

2.52

4.33

1.2

u/ml

16.8

3.4

0.42

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

11.75

4.28

12.6

5.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.91

4.27

1.9

1.3

—

(40761535) Cells panel - Urine sediment

555

1.63

4.21

6.2

3.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

3.46

4.20

2.4

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

647

5933

1.42

4.13

35.1

13.3

ml/min/173m2

77.5

80.3

1.61

556

4862

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.39

4.09

2.5

3.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

4.39

4.09

2.5

3.1

—

(3020393) Adenovirus Ag [Presence] in Stool

4.39

4.09

1.6

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

3.55

4.06

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

636

5824

1.41

4.02

8.0

5.9

mmol/mol

42.4

39.9

5.54

592

5382

(3000012) Reticulocyte production index

3.46

3.91

2.6

1.9

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

107

2.38

3.86

1.1

1.2

u/ml

4.1

5.8

0.29

(4306422)

2.51

3.82

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

3.10

3.82

2.1

1.6

—

(3004451) EKG impression Narrative

3.57

3.77

1.8

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

12.07

3.77

4.0

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

2.54

3.74

2.1

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

328

1.76

3.73

2.9

3.1

pmol/l

4.8

4.6

0.14

291

(3013512) EKG study

237

1889

1.36

3.71

5.2

4.0

—

(3051651) Icteric interference index of Serum or Plasma

3.04

3.70

3.0

3.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

159

1187

1.42

3.69

1.6

—

(3014271) Vancomycin [Susceptibility]

3.29

3.63

3.8

2.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.46

3.63

2.0

2.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

100

686

1.52

3.57

4.2

ug/l

5.3

23.7

0.96

584

(4024509)

3.08

3.54

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

6.20

3.50

1.4

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

6.20

3.50

3.5

4.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

3.37

3.48

12.2

11.7

nmol/l

718.0

827.6

0.52

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

3.37

3.48

17.4

16.0

nmol/l

1479.9

1412.4

0.17

(40768795) Lymph node Pathology biopsy report

2.69

3.41

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

203

1.91

3.40

1.4

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

7.05

3.37

1.1

1.3

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.75

3.34

1.5

2.1

u/field

3.1

3.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

2.33

3.29

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

660

6144

1.37

3.28

5.6

4.5

mmol/l

6.2

6.0

2.26

610

5558

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

8.62

3.26

1.5

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

206

1.89

3.26

1.4

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

2.61

3.23

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.19

3.22

1.4

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

2.50

3.14

3.4

3.5

—

(3016018) Differential panel - Cerebral spinal fluid

2.57

3.14

1.2

2.9

—

(3032057) Clostridioides difficile [Presence] in Stool

5.04

3.05

2.0

2.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

134

1003

1.40

3.05

1.3

1.2

iu/ml

48.8

36.8

0.23

294

(3051593) INR in Capillary blood by Coagulation assay

3.48

3.05

1.9

17.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.87

3.02

4.0

7.7

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

5.87

3.02

1.3

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

212

1.83

3.01

1.4

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

2.43

2.98

1.5

52.4

66.2

—

(3023410) Appearance of Cerebral spinal fluid

2.49

2.97

2.3

3.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.36

2.91

1.5

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

5.42

2.87

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

471

0.52

2.78

1.7

1.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.03

2.73

1.4

1.2

—

(21494755) Public health laboratory ask at order entry panel

542

0.56

2.70

1.1

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.24

2.68

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.24

2.68

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.78

2.67

1.8

1.3

—

(3045414) Leukocytes [Presence] in Urine

275

1.67

2.64

2.4

1.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

141

1.95

2.63

1.9

1.7

iu/l

4.0

5.5

—

(4015189)

4.70

2.60

1.9

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.63

2.58

3.1

2.2

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.03

2.57

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

4.03

2.57

13.5

8.3

—

(3021788) Differential panel - Synovial fluid

129

1.97

2.52

1.5

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

728

1.41

2.51

2.1

1.7

1.6

1.5

0.96

637

(3048689) Calprotectin [Mass/mass] in Stool

108

808

1.39

2.48

2.8

2.4

ug/g

140.5

124.8

0.15

636

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

4.40

2.48

2.3

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.97

2.42

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

2.40

1.0

1.3

—

(4268621)

2.25

2.28

2.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.48

2.28

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

2.05

2.27

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

4.64

2.27

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

3.50

2.27

1.1

1.0

—

(40768804) Tissue Pathology biopsy report

284

2453

1.24

2.24

2.3

2.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.58

2.21

9.6

11.6

mmol/l

5.2

7.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

5.58

2.21

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

226

1.67

2.21

2.4

u/l

803.1

3026.3

0.99

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

3.02

2.15

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

3.02

2.15

1.1

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

340

1.53

2.15

1.4

1.3

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

2.39

2.13

1.0

1.1

—

7.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2.07

2.12

3.5

2.3

33.1

32.9

0.05

(40768797) Stomach Pathology biopsy report

111

860

1.34

2.06

1.3

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.52

2.06

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.52

2.06

1.0

1.3

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.10

2.01

1.3

1.2

—

1.0

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1.98

2.01

1.3

—

(40768441) Liver Pathology biopsy report

2.30

1.98

1.8

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

134

1.81

1.97

1.3

1.2

u/ml

0.5

3.3

1.87

(3044007) Cell count panel - Peritoneal fluid

3.35

1.97

3.7

1.6

—

(3049717) Cytology report of Urine Cyto stain

290

1.55

1.96

2.3

2.8

—

(3045424) Erythrocytes [Presence] in Urine

1.96

1.6

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

1.94

1.91

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

212

1.63

1.91

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

342

1.49

1.89

2.8

2.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

136

1.79

1.89

1.1

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

2.33

1.88

1.2

1.3

—

(4198724)

3.20

1.88

1.9

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

120

955

1.30

1.86

1.2

1.3

u/ml

8.3

10.2

0.17

353

(3043410) Blood group antigens tested for on Red Blood Cells

3.06

1.80

4.4

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

2.78

1.79

1.1

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

2.19

1.78

1.5

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

154

1.71

1.78

1.2

1.3

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

2.46

1.76

1.0

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

117

1.82

1.75

1.1

u/ml

7.6

4.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

2.93

1.72

5.4

2.2

u/l

199.1

199.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.86

1.71

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

2.08

1.71

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

3.17

1.66

11.8

8.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

2.11

1.66

1.3

1.2

u/l

45.7

129.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.81

1.65

1.1

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

198

1696

1.22

1.64

1.7

mmol/l

1.5

1.3

1.21

177

1411

(3005033) Fetal Nuchal fold Thickness US

130

0.38

1.63

1.6

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

130

0.38

1.63

1.6

1.5

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

3.59

1.61

23.4

19.6

umol/l

0.6

0.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

128

1.74

1.61

1.1

1.2

—

2.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.34

1.60

1.5

1.2

—

(3034426) Prothrombin time (PT)

3.01

1.58

1.3

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

100

795

1.29

1.58

4.9

4.5

32.2

31.8

0.12

528

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

309

0.57

1.56

1.3

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

2.05

1.54

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

171

1.60

1.47

2.7

2.5

ug/min

44.3

123.1

1.80

107

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.24

1.47

1.0

1.2

—

70.4

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.38

1.46

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.38

1.46

1.3

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

650

6227

1.21

1.43

5.1

4.4

mmol/l

4.2

4.5

10.40

597

5731

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

662

6354

1.21

1.42

5.5

4.9

mmol/l

2.4

2.7

13.58

607

5808

(40768443) Skin Pathology biopsy report

288

1.45

1.41

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

2.26

1.40

1.3

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.19

1.40

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.19

1.40

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.19

1.40

1.2

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

624

5959

1.20

1.40

4.7

3.9

mmol/l

1.4

1.3

2.36

575

5430

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

223

1.50

1.38

1.7

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

234

0.55

1.35

1.8

1.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.34

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.34

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

2.14

1.34

1.2

1.1

—

(3002256) Pathology report gross observation

797

1.26

1.32

1.3

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

134

0.44

1.28

1.5

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

313

0.63

1.24

1.5

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

778

1.25

1.22

18.7

7.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.17

1.21

2.1

2.7

—

(3004616) Nuclear Ab [Presence] in Serum

1.84

1.20

1.0

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

1.89

1.18

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

199

1.47

1.16

1.2

1.4

ug/g

275.6

292.2

0.17

112

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1.74

1.15

2.3

2.6

mg/l

14.6

22.1

—

(3022145) Colonoscopy Study observation

705

1.25

1.11

1.5

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

160

1.52

1.10

1.1

1.2

u/ml

7.0

6.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

2.39

1.09

1.0

1.1

40.8

29.7

—

(3033799) Differential panel - Peritoneal fluid

2.39

1.09

1.8

1.9

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1.93

1.06

1.0

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

170

1.49

1.06

1.1

1.2

—

21.4

—

(40765096) Chromosome analysis panel by Banding

2.28

1.03

1.0

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1.72

0.99

1.2

1.1

u/ml

4.6

5.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

159

0.56

0.99

1.7

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

159

0.56

0.99

1.7

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

159

0.56

0.99

1.7

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

159

0.56

0.99

1.7

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.98

0.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

579

1.25

0.97

7.6

3.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.81

0.97

1.0

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.96

0.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

116

0.51

0.94

1.5

—

(4027681)

1.90

0.94

1.4

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

2.15

0.91

4.2

2.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1.70

0.89

1.0

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.01

0.87

1.3

1.4

52.2

57.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.01

0.87

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

270

2490

1.13

0.85

4.5

5.0

ug/l

2.3

3.2

1.03

241

2220

(3009214) Lutropin [Units/volume] in Serum or Plasma

196

1.39

0.85

1.5

1.6

u/l

14.4

8.0

1.03

156

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

218

1992

1.13

0.80

4.0

4.4

22.9

21.3

0.65

958

(36660697) Celiac disease serology panel - Serum

548

1.22

0.80

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.79

0.0

2.8

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.79

0.0

5.5

—

(4094501)

151

0.59

0.79

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.77

0.76

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.09

0.74

7.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

636

6183

1.13

0.73

5.0

4.3

mmol/l

1.4

4.51

582

5654

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.01

0.72

1.2

1.3

u/ml

5.5

25.3

—

(3044941) Cell count panel - Synovial fluid

110

1.46

0.68

1.4

1.5

—

(3011648) Oxygen content in Venous blood

1.65

0.68

6.1

14.2

11.7

11.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.86

0.68

1.0

1.1

iu/ml

1034.8

187.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.86

0.68

1.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

179

1.35

0.67

1.5

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.50

0.67

5.6

2.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.63

0.67

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

349

1.24

0.66

4.7

3.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.60

0.65

1.1

1.2

—

(44813793)

1.60

0.65

1.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

629

1.18

0.63

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

686

1.17

0.62

2.1

2.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.67

0.61

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.67

0.61

1.6

1.2

u/l

36.6

22.9

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

1.67

0.61

1.6

1.2

u/l

108.2

74.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1.48

0.61

1.2

1.1

u/ml

3.3

7.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.60

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1.51

0.60

1.2

—

66.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1.54

0.59

1.9

1.2

nmol/l

1.4

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.57

0.58

1.6

1.4

—

(4211845)

1.67

0.56

1.2

2.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

130

1428

0.89

0.55

2.8

3.0

ug/l

0.7

0.8

0.20

954

(3028300) Cannabinoids [Presence] in Urine

281

0.78

0.52

10.0

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

356

0.81

0.50

1.0

—

(3027008) Opiates [Presence] in Urine

279

0.78

0.49

10.0

1.6

—

(3027944) Amphetamines [Presence] in Urine

278

0.79

0.48

3.5

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.53

0.48

2.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

760

1.13

0.48

2.2

—

(3014051) Protein [Presence] in Urine by Test strip

155

1.30

0.47

3.3

2.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

1.48

0.47

4.0

3.2

nmol/l

4.2

5.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

176

0.73

0.46

1.5

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

276

0.79

0.46

10.0

1.6

—

(40768800) Prostate Pathology biopsy report

153

0.72

0.46

1.0

1.2

—

(4034850)

192

1.26

0.45

28.3

11.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

122

1.32

0.42

1.9

1.7

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

332

1.18

0.42

2.1

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.57

0.42

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

1.57

0.42

1.2

3.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.52

0.41

1.4

1.2

nmol/l

172.8

149.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.00

0.41

0.0

1.2

—

(3016879) Cocaine [Presence] in Urine

260

0.80

0.40

10.4

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

162

1516

1.09

0.40

1.2

1.3

u/ml

2.7

1.8

0.32

372

(3025130) Human papilloma virus identified in Specimen

1.31

0.39

2.9

1.9

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

1.43

0.39

2.4

1.5

g/l

1.0

0.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

137

0.73

0.39

2.8

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.00

0.39

0.0

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1.38

0.38

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

402

1.15

0.38

2.2

2.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.43

0.35

1.0

—

(40768793) Breast Pathology biopsy report

124

0.72

0.35

1.1

1.3

—

(3020961) Endomysium IgA Ab [Titer] in Serum

349

0.85

0.33

1.1

—

123.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

774

0.91

0.30

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

166

1.21

0.30

1.6

1.7

e6/l

38858.5

17611.0

0.43

121

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.21

0.26

1.5

1.3

nmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

682

0.92

0.24

1.6

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.27

0.24

1.1

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.32

0.23

1.4

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

125

1.20

0.22

13.3

2.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.8

—

77.3

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.21

0.0

2.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

10.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.21

0.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

188

0.85

0.21

16.3

2.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

402

1.10

0.21

1.1

1.2

iu/ml

85.8

119.2

0.36

152

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

164

1.16

0.20

1.6

1.7

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

221

1.14

0.20

1.7

1.6

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.20

0.0

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

133

0.82

0.19

1.8

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.71

0.16

1.6

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

225

0.89

0.16

9.2

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

206

1.12

0.16

1.6

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

151

0.86

0.16

1.3

1.6

—

(3008898) HLA-B27 [Presence]

212

0.89

0.14

1.1

—

(1002224) Polysomnography panel

230

0.91

0.11

1.0

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

208

0.91

0.10

1.8

1.7

nmol/l

41.5

38.8

0.18

196

(3017446) Testosterone [Moles/volume] in Serum or Plasma

561

0.96

0.08

2.3

2.2

nmol/l

11.2

12.8

0.68

494

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.81

0.07

1.5

1.3

—

0.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1.07

0.07

1.4

1.3

nmol/l

0.7

0.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

122

0.90

0.07

2.5

2.7

u/ml

3.2

37.8

0.55

116

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

111

1.08

0.04

1.3

1.4

pmol/l

119.9

305.7

0.71

111

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

137

0.95

0.01

1.6

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

193

1.04

0.01

5.0

4.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

103

0.97

0.00

1.1

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

377

1.01

0.00

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

131

0.99

0.00

1.2

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

23.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(4146454)

1.00

0.00

5.0

2.5

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

181.3

—

(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma

0.00

0.0

2.6

—

25.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

0.0

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.99

0.00

1.1

1.0

—

(42870560) Thyrotropin [Units/volume] in Cord blood

0.88

0.00

1.0

mu/l

9.8

8.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.00

0.0

1.5

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

140

1.00

0.00

1.7

1.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint VIRALPNEUMOKNOWN and mortality.

Females

Parameter	HR [95% CI]	p-value
VIRALPNEUMOKNOWN	3.187 [2.11, 4.8]	< 0.001
Birth year	0.999 [0.99, 1.01]	0.755

During the follow-up period (1.1.1998 — 31.12.2019), 411 out of 2247 females with VIRALPNEUMOKNOWN died.

Males

Parameter	HR [95% CI]	p-value
VIRALPNEUMOKNOWN	3.92 [2.56, 6.01]	< 0.001
Birth year	0.984 [0.97, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 456 out of 2423 males with VIRALPNEUMOKNOWN died.

Mortality risk

Mortality risk for people of age

years, who have VIRALPNEUMOKNOWN.

N-year risk	Females	Males
1	0.264%	0.744%
5	1.961%	4.201%
10	5.172%	9.987%
15	9.739%	17.464%
20	16.718%	27.906%

Relationships between endpoints

↥

Index endpoint: VIRALPNEUMOKNOWN – Viral pneumonia (known virus, not influenza)

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Viral pneumonia (known virus, not influenza)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints